Skip to main content
SpringerLink
Log in

Making Decisions About Implantable Cardioverter-Defibrillators from Implantation to End of Life: An Integrative Review of Patients’ Perspectives

  • Review Article
  • Published:
The Patient - Patient-Centered Outcomes Research Aims and scope Submit manuscript

Abstract

Implantable cardioverter-defibrillators (ICDs) are used for patients at risk of sudden cardiac death. Patients considering ICD therapy are faced with several preference-sensitive decisions. Our aim was to explore patients’ ICD decision-making experiences from the decision to implant to the consideration of deactivation at end of life. We conducted an integrative review using Whittemore and Knafl’s five steps. MEDLINE, CINAHL, PubMed, PsycINFO, and the Cochrane library were searched from 2000 to 2013. Eligible studies focused on the patient response regarding ICD decision-making. Key themes were identified and used as a framework to discuss findings through the chronological course of decisions faced by these patients. Of 354 potential citations, 25 articles were included. The trajectory of key decision points was whether or not to initiate ICD therapy, replace the battery, and deactivate at end of life. Three common themes from patients’ perspectives were the influence of the patient–practitioner consultation on knowledge uptake, patients’ decision-making preference, and their desire to live. Patients faced with ICD-related decisions often misunderstood the functionality of their ICD, or overestimated its benefit. They also expressed mixed preferences for the desire to be involved in decisions. The decisions around ICDs are particularly difficult for patients given the life and death trade off. Clinicians involved in the care of these patients could better support them by verifying their understanding and eliciting their preferences. Using a shared decision-making approach has the potential to achieve improved patient outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225–37.

    Article  CAS  PubMed  Google Scholar 

  2. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877–83.

    Article  PubMed  Google Scholar 

  3. Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J. 2000;21:2071–8.

    Article  CAS  PubMed  Google Scholar 

  4. Epstein AE, Dimarco JP, Ellenbogen KA, Estes NA III, Freedman RA, Gettes LS, et al. ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. Heart Rhythm. 2008;5:e1–62.

    Article  PubMed  Google Scholar 

  5. Krahn AD, Lee DS, Birnie D, Healey JS, Crystal E, Dorian P, et al. Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the Ontario ICD Database. Circ Arrhythm Electrophysiol. 2011;4:136–42.

    Article  PubMed  Google Scholar 

  6. Nery PB, Fernandes R, Nair GM, Sumner GL, Ribas CS, Menon SM, et al. Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences. J Cardiovasc Electrophysiol. 2010;21:786–90.

    PubMed  Google Scholar 

  7. Poole JE, Gleva MJ, Mela T, Chung MK, Uslan DZ, Borge R, et al. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation. 2010;122:1553–61.

    Article  PubMed  Google Scholar 

  8. Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, et al. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol. 2008;51:1357–65.

    Article  PubMed  Google Scholar 

  9. Kapa S, Rotondi-Trevisan D, Mariano Z, Aves T, Irvine J, Dorian P, et al. Psychopathology in patients with ICDs over time: results of a prospective study. Pacing Clin Electrophysiol. 2010;33:198–208.

    Article  PubMed  Google Scholar 

  10. Sears SF Jr, Conti JB, Curtis AB, Saia TL, Foote R, Wen F. Affective distress and implantable cardioverter defibrillators: cases for psychological and behavioral interventions. Pacing Clin Electrophysiol. 1999;22:1831–4.

    Article  PubMed  Google Scholar 

  11. Goldstein NE, Lampert R, Bradley E, Lynn J, Krumholz HM. Management of implantable cardioverter defibrillators in end-of-life care. Ann Intern Med. 2004;141:835–8.

    Article  PubMed  Google Scholar 

  12. Nambisan V, Chao D. Dying and defibrillation: a shocking experience. Palliat Med. 2004;18:482–3.

    Article  PubMed  Google Scholar 

  13. Sherazi S, McNitt S, Aktas MK, Polonsky B, Shah AH, Moss AJ, et al. End-of-life care in patients with implantable cardioverter defibrillators: a MADIT-II substudy. Pacing Clin Electrophysiol. 2013;36:1273–9.

    PubMed  Google Scholar 

  14. O’Connor AM, Wennberg JE, Legare F, Llewellyn-Thomas HA, Moulton BW, Sepucha KR, et al. Toward the ‘tipping point’: decision aids and informed patient choice. Health Aff (Millwood). 2007;26:716–25.

    Article  Google Scholar 

  15. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;128:e240–319.

    Article  PubMed  Google Scholar 

  16. Elwyn G, O’Connor A, Stacey D, Volk R, Edwards A, Coulter A, et al. Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ. 2006;333:417.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Ratliff A, Angell M, Dow RW, Kuppermann M, Nease RF Jr, Fisher R, et al. What is a good decision? Eff Clin Pract. 1999;2:185–97.

    CAS  PubMed  Google Scholar 

  18. Elwyn G, Laitner S, Coulter A, Walker E, Watson P, Thomson R. Implementing shared decision making in the NHS. BMJ. 2010;341:c5146.

    Article  PubMed  Google Scholar 

  19. Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Soc Sci Med. 1997;44:681–92.

    Article  CAS  PubMed  Google Scholar 

  20. Charles C, Gafni A, Whelan T. Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model. Soc Sci Med. 1999;49:651–61.

    Article  CAS  PubMed  Google Scholar 

  21. Laine C, Davidoff F. Patient-centered medicine. A professional evolution. JAMA. 1996;275:152–6.

    Article  CAS  PubMed  Google Scholar 

  22. Government of Ontario. Health Care Consent Act. In: S.O.1996 ed, 1996:c.2-Sched. A.

  23. O’Connor AM, Drake ER, Wells GA, Tugwell P, Laupacis A, Elmslie T. A survey of the decision-making needs of Canadians faced with complex health decisions. Health Expect. 2003;6:97–109.

    Article  PubMed  Google Scholar 

  24. Whittemore R, Knafl K. The integrative review: updated methodology. J Adv Nurs. 2005;52:546–53.

    Article  PubMed  Google Scholar 

  25. O’Connor AM, Tugwell P, Wells GA, Elmslie T, Jolly E, Hollingworth G, et al. A decision aid for women considering hormone therapy after menopause: decision support framework and evaluation. Patient Educ Couns. 1998;33:267–79.

    Article  PubMed  Google Scholar 

  26. Pace R, Pluye P, Bartlett G, Macaulay AC, Salsberg J, Jagosh J, et al. Testing the reliability and efficiency of the pilot Mixed Methods Appraisal Tool (MMAT) for systematic mixed studies review. Int J Nurs Stud. 2012;49:47–53.

    Article  PubMed  Google Scholar 

  27. Pluye P, Gagnon MP, Griffiths F, Johnson-Lafleur J. A scoring system for appraising mixed methods research, and concomitantly appraising qualitative, quantitative and mixed methods primary studies in Mixed Studies Reviews. Int J Nurs Stud. 2009;46:529–46.

    Article  PubMed  Google Scholar 

  28. Hauptman PJ, Chibnall JT, Guild C, Armbrecht ES. Patient perceptions, physician communication, and the implantable cardioverter-defibrillator. JAMA Intern Med. 2013;173:571–7.

    Article  PubMed  Google Scholar 

  29. Agard A, Lofmark R, Edvardsson N, Ekman I. Views of patients with heart failure about their role in the decision to start implantable cardioverter defibrillator treatment: prescription rather than participation. J Med Ethics. 2007;33:514–8.

    Article  PubMed Central  PubMed  Google Scholar 

  30. Carroll SL, Strachan PH, de Laat S, Schwartz L, Arthur HM. Patients’ decision making to accept or decline an implantable cardioverter defibrillator for primary prevention of sudden cardiac death. Health Expect. 2013;16:69–79.

    Article  PubMed Central  PubMed  Google Scholar 

  31. Groarke J, Beirne A, Buckley U, O’Dwyer E, Sugrue D, Keelan T, et al. Deficiencies in patients’ comprehension of implantable cardioverter defibrillator therapy. Pacing Clin Electrophysiol. 2012;35:1097–102.

    Article  PubMed  Google Scholar 

  32. Dodson JA, Fried TR, Van Ness PH, Goldstein NE, Lampert R. Patient preferences for deactivation of implantable cardioverter-defibrillators. JAMA Intern Med. 2013;173:377–9.

    Article  PubMed Central  PubMed  Google Scholar 

  33. Fluur C, Bolse K, Stromberg A, Thylén I. Patients’ experiences of the implantable cardioverter defibrillator (ICD); with a focus on battery replacement and end-of-life issues. Heart Lung. 2013;42:202–7.

    Article  PubMed  Google Scholar 

  34. Goldstein NE, Mehta D, Siddiqui S, Teitelbaum E, Zeidman J, Singson M, et al. “That’s like an act of suicide” Patients’ attitudes toward deactivation of implantable defibrillators. J Gen Intern Med. 2007;23:7–12.

    Article  PubMed Central  Google Scholar 

  35. Habal MV, Micevski V, Greenwood S, Delgado DH, Ross HJ. How aware of advanced care directives are heart failure patients, and are they using them? Can J Cardiol. 2011;27:376–81.

    Article  PubMed  Google Scholar 

  36. Kirkpatrick JN, Gottlieb M, Sehgal P, Patel R, Verdino RJ. Deactivation of implantable cardioverter defibrillators in terminal illness and end of life care. Am J Cardiol. 2012;109:91–4.

    Article  PubMed  Google Scholar 

  37. Stewart GC, Weintraub JR, Pratibhu PP, Semigran MJ, Camuso JM, Brooks K, et al. Patient expectations from implantable defibrillators to prevent death in heart failure. J Card Fail. 2010;16:106–13.

    Article  PubMed  Google Scholar 

  38. Strachan PH, Carroll SL, de Laat S, Schwartz L, Arthur HM. Patients’ perspectives on end-of-life issues and implantable cardioverter defibrillators. J Palliat Care. 2011;27:6–11.

    PubMed Central  PubMed  Google Scholar 

  39. Matlock DD, Nowels CT, Masoudi FA, Sauer WH, Bekelman DB, Main DS, et al. Patient and cardiologist perceptions on decision making for implantable cardioverter-defibrillators: a qualitative study. Pacing Clin Electrophysiol. 2011;34:1634–44.

    Article  PubMed  Google Scholar 

  40. Yuhas J, Mattocks K, Gravelin L, Remetz M, Foley J, Fazio R, et al. Patients’ attitudes and perceptions of implantable cardioverter-defibrillators: potential barriers to appropriate primary prophylaxis. Pacing Clin Electrophysiol. 2012;35:1179–87.

    Article  PubMed  Google Scholar 

  41. Matlock DD, Nowels CT, Bekelman DB. Patient perspectives on decision making in heart failure. J Card Fail. 2010;16:823–6.

    Article  PubMed  Google Scholar 

  42. Kantor PB, Bullinger JM, Gal CS. Patient decision-making modes and causes: a preliminary investigation. J Am Soc Inf Sci Technol. 2012;63:1339–49.

    Article  Google Scholar 

  43. Gibson DP, Kuntz KK, Levenson JL, Ellenbogen KA. Decision-making, emotional distress, and quality of life in patients affected by the recall of their implantable cardioverter defibrillator. Europace. 2008;10:540–4.

    Article  PubMed  Google Scholar 

  44. Thylén I, Moser DK, Chung ML, Miller J, Fluur C, Stromberg A. Are ICD recipients able to foresee if they want to withdraw therapy or deactivate defibrillator shocks? IJC Heart Vessels. 2013;1:22–31.

    Article  Google Scholar 

  45. Raphael CE, Koa-Wing M, Stain N, Wright I, Francis DP, Kanagaratnam P. Implantable cardioverter-defibrillator recipient attitudes towards device deactivation: how much do patients want to know? Pacing Clin Electrophysiol. 2011;34:1628–33.

    Article  PubMed  Google Scholar 

  46. Kapa S, Mueller PS, Hayes DL, Asirvatham SJ. Perspectives on withdrawing pacemaker and implantable cardioverter-defibrillator therapies at end of life: results of a survey of medical and legal professionals and patients. Mayo Clin Proc. 2010;85:981–90.

    Article  PubMed Central  PubMed  Google Scholar 

  47. Kramer DB, Kesselheim AS, Salberg L, Brock DW, Maisel WH. Ethical and legal views regarding deactivation of cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2011;107:1071–5.

    Article  PubMed Central  PubMed  Google Scholar 

  48. Pederson SS, Chaitsing R, Szili-Torok T, Jordaens L, Theuns D. Patients’ perspectives on deactivation of the implantable cardioverter-defibrillator near the end of life. Am J Cardiol. 2013;111:1443–7.

    Article  Google Scholar 

  49. Kobza R, Erne P. End-of-life decisions in ICD patients with malignant tumors. Pacing Clin Electrophysiol. 2007;30:845–9.

    Article  PubMed  Google Scholar 

  50. Lewis WR, Luebke DL, Johnson NJ, Harrington MD, Costantini O, Aulisio MP. Withdrawing implantable defibrillator shock therapy in terminally ill patients. Am J Med. 2006;119:892–6.

    Article  PubMed  Google Scholar 

  51. Berger JT, Gorski M, Cohen T. Advance health planning and treatment preferences among recipients of implantable cardioverter defibrillators: an exploratory study. J Clin Ethics. 2006;17:72–8.

    PubMed  Google Scholar 

  52. Goldstein N, Bradley E, Zeidman J, Mehta D, Morrison RS. Barriers to conversations about deactivation of implantable defibrillators in seriously ill patients: results of a nationwide survey comparing cardiology specialists to primary care physicians. J Am Coll Cardiol. 2009;54:371–3.

    Article  PubMed Central  PubMed  Google Scholar 

  53. Matlock DD, Peterson PN, Heidenreich PA, Lucas FL, Malenka DJ, Wang Y, et al. Regional variation in the use of implantable cardioverter-defibrillators for primary prevention: results from the National Cardiovascular Data Registry. Circ Cardiovasc Qual Outcomes. 2011;4:114–21.

    Article  PubMed  Google Scholar 

  54. Stacey D, Légaré F, Col NF, Bennett CL, Barry MJ, Eden KB, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2014:CD001431.

  55. Healthwise. Heart rhythm problems: Should I get an implantable cardioverter-defibrillator (ICD)? https://www.healthwise.net/cochranedecisionaid/Content/StdDocument.aspx?DOCHWID=abk4103.

  56. Healthwise. Heart Failure: should I get an implantable cardioverter-defibrillator? 2013. https://www.healthwise.net/cochranedecisionaid/Content/StdDocument.aspx?DOCHWID=uf9848.

  57. Carroll SL, McGillion M, Stacey D, Healey JS, Browne G, Arthur HM, et al. Development and feasibility testing of decision support for patients who are candidates for an implantable defibrillator: a study protocol for a pilot randomized controlled trial. Trials. 2013;14:346.

    Article  PubMed Central  PubMed  Google Scholar 

  58. Fargelin A, Schneider CE. Enough: the failure of living will. Hastings Cent Rep. 2004;34:30–42.

    Article  Google Scholar 

  59. Bonow RO, Ganiats TG, Beam CT, Blake K, Casey DE Jr, Goodlin SJ, et al. ACCF/AHA/AMA-PCPI 2011 performance measures for adults with heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement. Circulation. 2012;125:2382–401.

    Article  PubMed  Google Scholar 

  60. Institute of Medicine. Crossing the quality chasm: a new health system for the 21st century. National Academy Press; 2001.

Download references

Acknowledgments

The authors have no conflicts of interest to disclose. No funding was received for the completing of this study.

Disclosures

The authors have no conflicts of interest to disclose. No funding was received for the completion of this study. Dr. Matlock was supported by a career development award from the National Institutes on Aging (K23AG040696).

Author contribution

KBL—Conception and design, article selection, analysis and interpretation of data, drafting the article, final approval.

DS—Critical revision of the article for important intellectual content, final approval.

DDM—Conception and design, article selection, analysis and interpretation of data, revising the article, final approval.

Author information

Authors and Affiliations

  1. School of Nursing, University of Ottawa, Ottawa, Canada

    Krystina B. Lewis & Dawn Stacey

  2. University of Ottawa Heart Institute, 40 Ruskin Street, Room H1285, Ottawa, K1Y4W7, Canada

    Krystina B. Lewis

  3. Ottawa Hospital Research Institute, Ottawa, Canada

    Dawn Stacey

  4. Department of Medicine, School of Medicine, University of Colorado, Aurora, USA

    Dan D. Matlock

Authors
  1. Krystina B. Lewis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dawn Stacey
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dan D. Matlock
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Krystina B. Lewis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lewis, K.B., Stacey, D. & Matlock, D.D. Making Decisions About Implantable Cardioverter-Defibrillators from Implantation to End of Life: An Integrative Review of Patients’ Perspectives. Patient 7, 243–260 (2014). https://doi.org/10.1007/s40271-014-0055-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40271-014-0055-2

Keywords

Search

Navigation